KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Other financing activities: 2014-2022

Historic Other financing activities for Incyte (INCY) over the last 6 years, with Mar 2022 value amounting to $14.2 million.

  • Incyte's Other financing activities fell 28.91% to $14.2 million in Q1 2022 from the same period last year, while for Mar 2022 it was $30.1 million, marking a year-over-year decrease of 34.00%. This contributed to the annual value of -$39,000 for FY2017, which is 100.28% down from last year.
  • Incyte's Other financing activities amounted to $14.2 million in Q1 2022, which was up 218.72% from -$12.0 million recorded in Q3 2021.
  • Incyte's 5-year Other financing activities high stood at $20.0 million for Q1 2021, and its period low was -$12.0 million during Q3 2021.
  • For the 3-year period, Incyte's Other financing activities averaged around $8.9 million, with its median value being $14.2 million (2022).
  • In the last 5 years, Incyte's Other financing activities skyrocketed by 37,856.10% in 2018 and then tumbled by 254.08% in 2021.
  • Over the past 5 years, Incyte's Other financing activities (Quarterly) stood at $2.4 million in 2018, then climbed by 28.34% to $3.1 million in 2019, then skyrocketed by 150.18% to $7.8 million in 2020, then tumbled by 254.08% to -$12.0 million in 2021, then decreased by 28.91% to $14.2 million in 2022.
  • Its Other financing activities stands at $14.2 million for Q1 2022, versus -$12.0 million for Q3 2021 and $20.0 million for Q1 2021.